|
OMIM |
Link |
Information gain |
01 |
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.00414506
|
|
|
CRMO
|
[NCBI]
|
0.00314329
|
|
|
megaduodenum and/or megacystis
|
[NCBI]
|
0.00237986
|
|
|
CF
|
[NCBI]
|
0.0016094
|
|
|
mucus inspissation of respiratory tract
|
[NCBI]
|
0.00158695
|
|
|
neutropenia, chronic familial
|
[NCBI]
|
0.00129011
|
|
|
onychotrichodysplasia and neutropenia
|
[NCBI]
|
0.00115302
|
|
|
spinal muscular atrophy, facioscapulohumeral type
|
[NCBI]
|
0.00115302
|
|
|
DSMA3
|
[NCBI]
|
0.00115302
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal dominant
|
[NCBI]
|
0.000933496
|
|
|
DIP
|
[NCBI]
|
0.000885629
|
|
|
visceral neuropathy, familial, autosomal recessive
|
[NCBI]
|
0.000844384
|
|
|
EMWX
|
[NCBI]
|
0.00079215
|
|
|
immotile cilia syndrome due to defective radial spokes
|
[NCBI]
|
0.00079215
|
|
|
azotemia, familial
|
[NCBI]
|
0.00079215
|
|
|
GLC1D
|
[NCBI]
|
0.00079215
|
|
|
MDD
|
[NCBI]
|
0.000595529
|
|
|
MGS
|
[NCBI]
|
0.000575205
|
|
|
IGAD1
|
[NCBI]
|
0.000553193
|
|
|
PCTT
|
[NCBI]
|
0.000544045
|
|
|
CCK
|
[NCBI]
|
0.000513352
|
|
|
PDR
|
[NCBI]
|
0.000493952
|
|
|
IGAN1
|
[NCBI]
|
0.000480119
|
|
|
trichohepatoenteric syndrome
|
[NCBI]
|
0.000441541
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal recessive
|
[NCBI]
|
0.000441541
|
|
|
actinic prurigo
|
[NCBI]
|
0.000346875
|
|
|
HMN7A
|
[NCBI]
|
0.000346875
|
|
|
peeling skin syndrome
|
[NCBI]
|
0.000325352
|
|
|
AD
|
[NCBI]
|
0.00031901
|
|
|
amyotrophy, monomelic
|
[NCBI]
|
0.000290172
|
|
|
panbronchiolitis, diffuse
|
[NCBI]
|
0.000290172
|
|
|
majeed syndrome
|
[NCBI]
|
0.000280814
|
|
|
basal ganglia calcification, idiopathic, childhood-onset
|
[NCBI]
|
0.000275439
|
|
|
EPO
|
[NCBI]
|
0.000270711
|
|
|
renal failure, progressive, with hypertension
|
[NCBI]
|
0.000262141
|
|
|
KLK3
|
[NCBI]
|
0.000259581
|
|
|
RA
|
[NCBI]
|
0.000250958
|
|
|
blue rubber bleb nevus
|
[NCBI]
|
0.00025004
|
|
|
osteolysis, hereditary, of carpal bones with nephropathy
|
[NCBI]
|
0.000238949
|
|
|
mesothelioma, malignant
|
[NCBI]
|
0.000228725
|
|
|
MBP
|
[NCBI]
|
0.000216266
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
0.000210141
|
|
|
IFNA1
|
[NCBI]
|
0.000187918
|
|
|
CRC
|
[NCBI]
|
0.000181929
|
|
|
SPINK1
|
[NCBI]
|
0.000164838
|
|
|
tropical calcific pancreatitis
|
[NCBI]
|
0.00015647
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.000156401
|
|
|
APC
|
[NCBI]
|
0.000152732
|
|
|
PRSS1
|
[NCBI]
|
0.000142317
|
|
|
RNASE3
|
[NCBI]
|
0.000139802
|
|
|
CFTR
|
[NCBI]
|
0.00013313
|
|
|
MAFD6
|
[NCBI]
|
0.000132284
|
|
|
EGFR
|
[NCBI]
|
0.000130488
|
|
|
LPIN2
|
[NCBI]
|
0.000128371
|
|
|
TNF
|
[NCBI]
|
0.000123252
|
|
|
CJD
|
[NCBI]
|
0.000112561
|
|
|
cirrhosis, familial
|
[NCBI]
|
0.00010964
|
|
|
BCPM
|
[NCBI]
|
0.000101853
|
|
|
CRH
|
[NCBI]
|
9.70276e-05
|
|
|
PWS
|
[NCBI]
|
9.51216e-05
|
|
|
MPO
|
[NCBI]
|
9.49697e-05
|
|
|
RP
|
[NCBI]
|
9.49289e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
9.13718e-05
|
|
|
CVID
|
[NCBI]
|
8.73834e-05
|
|
|
PEPD
|
[NCBI]
|
8.31466e-05
|
|
|
young syndrome
|
[NCBI]
|
7.35654e-05
|
|
|
behcet syndrome
|
[NCBI]
|
7.12755e-05
|
|
|
spinal muscular atrophy with microcephaly and mental subnormality
|
[NCBI]
|
7.01831e-05
|
|
|
lymphoblastic transformation, inhibition of
|
[NCBI]
|
7.01831e-05
|
|
|
lymphokine deficiency
|
[NCBI]
|
7.01831e-05
|
|
|
pancreatic insufficiency, combined exocrine
|
[NCBI]
|
7.01831e-05
|
|
|
diarrhea, chronic, with villous atrophy
|
[NCBI]
|
7.01831e-05
|
|
|
diarrhea 4, malabsorptive, congenital
|
[NCBI]
|
7.01831e-05
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
6.96822e-05
|
|
|
leukodystrophy, adult-onset, autosomal dominant
|
[NCBI]
|
6.87419e-05
|
|
|
REG3A
|
[NCBI]
|
6.64789e-05
|
|
|
NFKB1
|
[NCBI]
|
6.60386e-05
|
|
|
kartagener syndrome
|
[NCBI]
|
6.36029e-05
|
|
|
CGD
|
[NCBI]
|
6.14932e-05
|
|
|
polycythemia vera
|
[NCBI]
|
6.14027e-05
|
|
|
opitz syndrome
|
[NCBI]
|
6.09795e-05
|
|
|
PI
|
[NCBI]
|
5.97519e-05
|
|
|
CTSE
|
[NCBI]
|
5.83827e-05
|
|
|
CPB1
|
[NCBI]
|
5.83827e-05
|
|
|
PRSS2
|
[NCBI]
|
5.83827e-05
|
|
|
APOE
|
[NCBI]
|
5.42828e-05
|
|
|
PCD
|
[NCBI]
|
5.3376e-05
|
|
|
FIP1L1
|
[NCBI]
|
5.04031e-05
|
|
|
phosphoglycerate kinase 1 deficiency
|
[NCBI]
|
4.98814e-05
|
|
|
HGF
|
[NCBI]
|
4.94418e-05
|
|
|
AVP
|
[NCBI]
|
4.89988e-05
|
|
|
thrombocytopenia, cyclic
|
[NCBI]
|
4.79254e-05
|
|
|
nephropathy, chronic tubulointerstitial
|
[NCBI]
|
4.79254e-05
|
|
|
myelocytic leukemia-like syndrome, familial, chronic
|
[NCBI]
|
4.79254e-05
|
|
|
leg ulcers, familial, of juvenile onset
|
[NCBI]
|
4.79254e-05
|
|
|
pancreatitis, sclerosing cholangitis, and sicca complex
|
[NCBI]
|
4.79254e-05
|
|
|
LSA
|
[NCBI]
|
4.71679e-05
|
|
|
G6PD
|
[NCBI]
|
4.63602e-05
|
|
|
VRNI
|
[NCBI]
|
4.63251e-05
|
|
|
SLC6A3
|
[NCBI]
|
4.62194e-05
|
|
|
DNASE2
|
[NCBI]
|
4.57636e-05
|
|
|
PRPS2
|
[NCBI]
|
4.57636e-05
|
|
|
DDAH1
|
[NCBI]
|
4.57636e-05
|
|
|
S100A6
|
[NCBI]
|
4.57636e-05
|
|
|
paget disease, juvenile
|
[NCBI]
|
4.56634e-05
|
|
|
MUC1
|
[NCBI]
|
4.4961e-05
|
|
|
PG
|
[NCBI]
|
4.3145e-05
|
|
|
OCP
|
[NCBI]
|
4.28922e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
4.263e-05
|
|
|
HSAN2
|
[NCBI]
|
4.20297e-05
|
|
|
IL10
|
[NCBI]
|
3.98093e-05
|
|
|
CELIAC3
|
[NCBI]
|
3.96581e-05
|
|
|
peeling skin syndrome, acral type
|
[NCBI]
|
3.96581e-05
|
|
|
epstein-barr virus, susceptibility to chronic infection by
|
[NCBI]
|
3.96581e-05
|
|
|
AI1G
|
[NCBI]
|
3.96581e-05
|
|
|
myasthenia, limb-girdle, autoimmune
|
[NCBI]
|
3.96581e-05
|
|
|
chorea, benign familial
|
[NCBI]
|
3.96581e-05
|
|
|
CTGF
|
[NCBI]
|
3.96325e-05
|
|
|
SCN1
|
[NCBI]
|
3.88494e-05
|
|
|
MOG
|
[NCBI]
|
3.87867e-05
|
|
|
tyrosinemia, type i
|
[NCBI]
|
3.87659e-05
|
|
|
AGS1
|
[NCBI]
|
3.73997e-05
|
|
|
gm1-gangliosidosis, type iii
|
[NCBI]
|
3.73997e-05
|
|
|
PGK1
|
[NCBI]
|
3.64773e-05
|
|
|
EPS
|
[NCBI]
|
3.60314e-05
|
|
|
LOCS
|
[NCBI]
|
3.43647e-05
|
|
|
MODY4
|
[NCBI]
|
3.43647e-05
|
|
|
BDNF
|
[NCBI]
|
3.25622e-05
|
|
|
IL6
|
[NCBI]
|
3.21753e-05
|
|
|
STMN2
|
[NCBI]
|
3.20828e-05
|
|
|
TMEM49
|
[NCBI]
|
3.20828e-05
|
|
|
DMGDH
|
[NCBI]
|
3.20828e-05
|
|
|
SLC4A3
|
[NCBI]
|
3.20828e-05
|
|
|
OCLN
|
[NCBI]
|
3.20828e-05
|
|
|
SMA2
|
[NCBI]
|
3.12341e-05
|
|
|
FA
|
[NCBI]
|
2.9863e-05
|
|
|
FOXP3
|
[NCBI]
|
2.97172e-05
|
|
|
FGF23
|
[NCBI]
|
2.91957e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
2.88282e-05
|
|
|
encephalopathy, ethylmalonic
|
[NCBI]
|
2.74344e-05
|
|
|
CCAL2
|
[NCBI]
|
2.7279e-05
|
|
|
HOMER1
|
[NCBI]
|
2.69814e-05
|
|
|
CD81
|
[NCBI]
|
2.69814e-05
|
|
|
ITCH
|
[NCBI]
|
2.69814e-05
|
|
|
JUND
|
[NCBI]
|
2.69814e-05
|
|
|
AK1
|
[NCBI]
|
2.69106e-05
|
|
|
TNFRSF1B
|
[NCBI]
|
2.6085e-05
|
|
|
autonomic control, congenital failure of
|
[NCBI]
|
2.55456e-05
|
|
|
CCL21
|
[NCBI]
|
2.53007e-05
|
|
|
GIP
|
[NCBI]
|
2.51976e-05
|
|
|
glycogen storage disease i
|
[NCBI]
|
2.50172e-05
|
|
|
PPCRA
|
[NCBI]
|
2.49349e-05
|
|
|
whim syndrome
|
[NCBI]
|
2.49349e-05
|
|
|
optic atrophy 1 and deafness
|
[NCBI]
|
2.49349e-05
|
|
|
CINCA
|
[NCBI]
|
2.49349e-05
|
|
|
thrombophilia
|
[NCBI]
|
2.49349e-05
|
|
|
tyrosinemia, type iii
|
[NCBI]
|
2.49349e-05
|
|
|
PTHLH
|
[NCBI]
|
2.44574e-05
|
|
|
NPPA
|
[NCBI]
|
2.43562e-05
|
|
|
ALGS1
|
[NCBI]
|
2.42106e-05
|
|
|
PPP1R12A
|
[NCBI]
|
2.37036e-05
|
|
|
IL12RB2
|
[NCBI]
|
2.37036e-05
|
|
|
KRT18
|
[NCBI]
|
2.37036e-05
|
|
|
TNFSF12
|
[NCBI]
|
2.37036e-05
|
|
|
REG1A
|
[NCBI]
|
2.37036e-05
|
|
|
NEUROG3
|
[NCBI]
|
2.37036e-05
|
|
|
RPL22
|
[NCBI]
|
2.37036e-05
|
|
|
MDS1
|
[NCBI]
|
2.37036e-05
|
|
|
TGM5
|
[NCBI]
|
2.37036e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
2.3634e-05
|
|
|
FCDT
|
[NCBI]
|
2.28261e-05
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
2.28261e-05
|
|
|
SMDP2
|
[NCBI]
|
2.28261e-05
|
|
|
pancreatic agenesis, congenital
|
[NCBI]
|
2.28261e-05
|
|
|
chondrodysplasia punctata, tibia-metacarpal type
|
[NCBI]
|
2.28261e-05
|
|
|
SMA3
|
[NCBI]
|
2.24689e-05
|
|
|
TNFSF15
|
[NCBI]
|
2.12919e-05
|
|
|
INDO
|
[NCBI]
|
2.12919e-05
|
|
|
LAG5
|
[NCBI]
|
2.12919e-05
|
|
|
MST1R
|
[NCBI]
|
2.12919e-05
|
|
|
VEGF
|
[NCBI]
|
2.11673e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
[NCBI]
|
2.10094e-05
|
|
|
NPHP2
|
[NCBI]
|
2.10094e-05
|
|
|
MODY2
|
[NCBI]
|
2.10094e-05
|
|
|
myeloperoxidase deficiency
|
[NCBI]
|
2.10094e-05
|
|
|
ASS
|
[NCBI]
|
2.08952e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
2.01388e-05
|
|
|
PRL
|
[NCBI]
|
1.98594e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
1.9788e-05
|
|
|
hyperostosis corticalis generalisata, benign form of worth, with torus palatinus
|
[NCBI]
|
1.94194e-05
|
|
|
glutathione synthetase deficiency
|
[NCBI]
|
1.94194e-05
|
|
|
hexokinase deficiency hemolytic anemia
|
[NCBI]
|
1.94194e-05
|
|
|
TNFSF4
|
[NCBI]
|
1.93903e-05
|
|
|
HLA-DPB1
|
[NCBI]
|
1.93903e-05
|
|
|
CHIA
|
[NCBI]
|
1.93903e-05
|
|
|
KIF1B
|
[NCBI]
|
1.93903e-05
|
|
|
LIP
|
[NCBI]
|
1.92126e-05
|
|
|
GCCR
|
[NCBI]
|
1.91197e-05
|
|
|
NTRK1
|
[NCBI]
|
1.91197e-05
|
|
|
SMA1
|
[NCBI]
|
1.89357e-05
|
|
|
FMF
|
[NCBI]
|
1.89026e-05
|
|
|
PTH
|
[NCBI]
|
1.87073e-05
|
|
|
ADIPOQ
|
[NCBI]
|
1.8626e-05
|
|
|
LPL
|
[NCBI]
|
1.85388e-05
|
|
|
ALB
|
[NCBI]
|
1.83482e-05
|
|
|
complement component 5 deficiency
|
[NCBI]
|
1.80106e-05
|
|
|
complement component 7 deficiency
|
[NCBI]
|
1.80106e-05
|
|
|
TG
|
[NCBI]
|
1.79911e-05
|
|
|
AGER
|
[NCBI]
|
1.78995e-05
|
|
|
PTGER2
|
[NCBI]
|
1.78258e-05
|
|
|
ANXA2
|
[NCBI]
|
1.78258e-05
|
|
|
CLDN11
|
[NCBI]
|
1.78258e-05
|
|
|
NT5C3
|
[NCBI]
|
1.78258e-05
|
|
|
TNNI3
|
[NCBI]
|
1.78258e-05
|
|
|
trifunctional protein deficiency
|
[NCBI]
|
1.67497e-05
|
|
|
ZAP70
|
[NCBI]
|
1.65009e-05
|
|
|
JMJD6
|
[NCBI]
|
1.65009e-05
|
|
|
EVI1
|
[NCBI]
|
1.65009e-05
|
|
|
LAMA3
|
[NCBI]
|
1.65009e-05
|
|
|
CBP2
|
[NCBI]
|
1.65009e-05
|
|
|
SLC10A2
|
[NCBI]
|
1.65009e-05
|
|
|
SELE
|
[NCBI]
|
1.65009e-05
|
|
|
RUNX1
|
[NCBI]
|
1.63975e-05
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
1.62012e-05
|
|
|
APOB
|
[NCBI]
|
1.58693e-05
|
|
|
CMT2A1
|
[NCBI]
|
1.56122e-05
|
|
|
BRIC1
|
[NCBI]
|
1.56122e-05
|
|
|
SPP1
|
[NCBI]
|
1.55505e-05
|
|
|
alopecia, androgenetic
|
[NCBI]
|
1.53881e-05
|
|
|
FBXO32
|
[NCBI]
|
1.5355e-05
|
|
|
CYP2A6
|
[NCBI]
|
1.5355e-05
|
|
|
CDO
|
[NCBI]
|
1.5355e-05
|
|
|
KRT8
|
[NCBI]
|
1.5355e-05
|
|
|
LTF
|
[NCBI]
|
1.5355e-05
|
|
|
PDCD1LG1
|
[NCBI]
|
1.5355e-05
|
|
|
IGHMBP2
|
[NCBI]
|
1.5355e-05
|
|
|
PXE
|
[NCBI]
|
1.51287e-05
|
|
|
PD
|
[NCBI]
|
1.49025e-05
|
|
|
HOMG3
|
[NCBI]
|
1.45789e-05
|
|
|
HMN5
|
[NCBI]
|
1.45789e-05
|
|
|
gm1-gangliosidosis, type ii
|
[NCBI]
|
1.45789e-05
|
|
|
morquio syndrome b
|
[NCBI]
|
1.45789e-05
|
|
|
EYA4
|
[NCBI]
|
1.43483e-05
|
|
|
RELA
|
[NCBI]
|
1.43483e-05
|
|
|
CALCRL
|
[NCBI]
|
1.41518e-05
|
|
|
MYOC
|
[NCBI]
|
1.38968e-05
|
|
|
JAK2
|
[NCBI]
|
1.38968e-05
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 1
|
[NCBI]
|
1.3635e-05
|
|
|
DSMA1
|
[NCBI]
|
1.3635e-05
|
|
|
INVS
|
[NCBI]
|
1.34526e-05
|
|
|
CXCL13
|
[NCBI]
|
1.34526e-05
|
|
|
SLC6A6
|
[NCBI]
|
1.34526e-05
|
|
|
GPR24
|
[NCBI]
|
1.34526e-05
|
|
|
PF4
|
[NCBI]
|
1.33927e-05
|
|
|
MG
|
[NCBI]
|
1.33786e-05
|
|
|
LCN2
|
[NCBI]
|
1.31685e-05
|
|
|
MODY
|
[NCBI]
|
1.31329e-05
|
|
|
ADA
|
[NCBI]
|
1.30433e-05
|
|
|
muckle-wells syndrome
|
[NCBI]
|
1.27684e-05
|
|
|
PHB
|
[NCBI]
|
1.26477e-05
|
|
|
ATP8B1
|
[NCBI]
|
1.26477e-05
|
|
|
CYBA
|
[NCBI]
|
1.26477e-05
|
|
|
NLRP3
|
[NCBI]
|
1.26477e-05
|
|
|
PDCD1
|
[NCBI]
|
1.26477e-05
|
|
|
SFTPB
|
[NCBI]
|
1.26477e-05
|
|
|
CP
|
[NCBI]
|
1.2496e-05
|
|
|
CD44
|
[NCBI]
|
1.19183e-05
|
|
|
SFTPC
|
[NCBI]
|
1.19183e-05
|
|
|
EIF2B5
|
[NCBI]
|
1.19183e-05
|
|
|
ABCB4
|
[NCBI]
|
1.19183e-05
|
|
|
GNRH1
|
[NCBI]
|
1.18422e-05
|
|
|
VDR
|
[NCBI]
|
1.17806e-05
|
|
|
UBTF
|
[NCBI]
|
1.12529e-05
|
|
|
ETS1
|
[NCBI]
|
1.12529e-05
|
|
|
HLA-DRA
|
[NCBI]
|
1.12529e-05
|
|
|
amyloidosis v
|
[NCBI]
|
1.12304e-05
|
|
|
CHS
|
[NCBI]
|
1.10714e-05
|
|
|
GAPDH
|
[NCBI]
|
1.10668e-05
|
|
|
GAL
|
[NCBI]
|
1.06625e-05
|
|
|
SELP
|
[NCBI]
|
1.06423e-05
|
|
|
HADHA
|
[NCBI]
|
1.06423e-05
|
|
|
LTC4S
|
[NCBI]
|
1.06423e-05
|
|
|
BHC
|
[NCBI]
|
1.05442e-05
|
|
|
LPG
|
[NCBI]
|
1.05442e-05
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
1.05442e-05
|
|
|
CDPX1
|
[NCBI]
|
1.05442e-05
|
|
|
glutaric acidemia i
|
[NCBI]
|
1.05442e-05
|
|
|
F3
|
[NCBI]
|
1.02042e-05
|
|
|
PPARD
|
[NCBI]
|
1.00792e-05
|
|
|
GRB2
|
[NCBI]
|
1.00792e-05
|
|
|
crouzon syndrome
|
[NCBI]
|
9.9056e-06
|
|
|
diarrhea 1, secretory chloride, congenital
|
[NCBI]
|
9.9056e-06
|
|
|
PTK2
|
[NCBI]
|
9.71821e-06
|
|
|
RIPK1
|
[NCBI]
|
9.55749e-06
|
|
|
MMP1
|
[NCBI]
|
9.55749e-06
|
|
|
IPF1
|
[NCBI]
|
9.55749e-06
|
|
|
NCF1
|
[NCBI]
|
9.55749e-06
|
|
|
IFNGR1
|
[NCBI]
|
9.55749e-06
|
|
|
TH
|
[NCBI]
|
9.37308e-06
|
|
|
POMC
|
[NCBI]
|
9.32317e-06
|
|
|
CCL17
|
[NCBI]
|
9.26136e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
9.10141e-06
|
|
|
CFB
|
[NCBI]
|
9.07244e-06
|
|
|
TACR1
|
[NCBI]
|
9.07244e-06
|
|
|
MAPK14
|
[NCBI]
|
9.07244e-06
|
|
|
COMP
|
[NCBI]
|
8.93071e-06
|
|
|
LBP
|
[NCBI]
|
8.83996e-06
|
|
|
TPI1
|
[NCBI]
|
8.61993e-06
|
|
|
XDH
|
[NCBI]
|
8.54422e-06
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
8.23025e-06
|
|
|
PI3
|
[NCBI]
|
8.19653e-06
|
|
|
CEACAM5
|
[NCBI]
|
7.9428e-06
|
|
|
RBP4
|
[NCBI]
|
7.79933e-06
|
|
|
HLA-B
|
[NCBI]
|
7.79933e-06
|
|
|
PCNA
|
[NCBI]
|
7.77988e-06
|
|
|
HIDS
|
[NCBI]
|
7.74017e-06
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
7.74017e-06
|
|
|
JBS
|
[NCBI]
|
7.74017e-06
|
|
|
GAS
|
[NCBI]
|
7.42582e-06
|
|
|
OPA1
|
[NCBI]
|
7.42582e-06
|
|
|
UGCG
|
[NCBI]
|
7.42582e-06
|
|
|
PFHB1A
|
[NCBI]
|
7.27949e-06
|
|
|
niemann-pick disease, type b
|
[NCBI]
|
7.27949e-06
|
|
|
PRF1
|
[NCBI]
|
7.07386e-06
|
|
|
EDN1
|
[NCBI]
|
7.07386e-06
|
|
|
SOCS1
|
[NCBI]
|
7.07386e-06
|
|
|
TTP
|
[NCBI]
|
6.84585e-06
|
|
|
VWM
|
[NCBI]
|
6.84585e-06
|
|
|
GALC
|
[NCBI]
|
6.74156e-06
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
6.43717e-06
|
|
|
sudden infant death syndrome
|
[NCBI]
|
6.43717e-06
|
|
|
IVA
|
[NCBI]
|
6.43717e-06
|
|
|
AFP
|
[NCBI]
|
6.42834e-06
|
|
|
SOX10
|
[NCBI]
|
6.42729e-06
|
|
|
PTK2B
|
[NCBI]
|
6.42729e-06
|
|
|
IBD1
|
[NCBI]
|
6.13523e-06
|
|
|
biotinidase deficiency
|
[NCBI]
|
6.0516e-06
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
6.0516e-06
|
|
|
COMT
|
[NCBI]
|
5.89298e-06
|
|
|
TNNT2
|
[NCBI]
|
5.84721e-06
|
|
|
GFAP
|
[NCBI]
|
5.73297e-06
|
|
|
GCDH
|
[NCBI]
|
5.57899e-06
|
|
|
TRPV1
|
[NCBI]
|
5.57899e-06
|
|
|
FGF1
|
[NCBI]
|
5.57899e-06
|
|
|
SLE
|
[NCBI]
|
5.52896e-06
|
|
|
GDNF
|
[NCBI]
|
5.44304e-06
|
|
|
EIG
|
[NCBI]
|
5.39108e-06
|
|
|
SLC6A4
|
[NCBI]
|
5.37381e-06
|
|
|
IKBKG
|
[NCBI]
|
5.32394e-06
|
|
|
CTLA4
|
[NCBI]
|
5.32394e-06
|
|
|
PARP1
|
[NCBI]
|
5.32394e-06
|
|
|
EV
|
[NCBI]
|
5.28107e-06
|
|
|
IL3
|
[NCBI]
|
5.08113e-06
|
|
|
CMH
|
[NCBI]
|
5.06314e-06
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
5.01788e-06
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
5.01788e-06
|
|
|
ADM
|
[NCBI]
|
4.96054e-06
|
|
|
NAT1
|
[NCBI]
|
4.84976e-06
|
|
|
MMP3
|
[NCBI]
|
4.84976e-06
|
|
|
ATF3
|
[NCBI]
|
4.84976e-06
|
|
|
IL18
|
[NCBI]
|
4.84976e-06
|
|
|
GPC3
|
[NCBI]
|
4.84976e-06
|
|
|
lactase persistence
|
[NCBI]
|
4.70983e-06
|
|
|
EKV
|
[NCBI]
|
4.70983e-06
|
|
|
VASP
|
[NCBI]
|
4.62908e-06
|
|
|
MBL2
|
[NCBI]
|
4.4394e-06
|
|
|
TP53
|
[NCBI]
|
4.42827e-06
|
|
|
phenylketonuria
|
[NCBI]
|
4.42827e-06
|
|
|
gm1-gangliosidosis, type i
|
[NCBI]
|
4.41815e-06
|
|
|
MCOPS7
|
[NCBI]
|
4.41815e-06
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
4.41815e-06
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
4.41815e-06
|
|
|
FGF7
|
[NCBI]
|
4.37247e-06
|
|
|
GHRH
|
[NCBI]
|
4.31687e-06
|
|
|
TNFSF10
|
[NCBI]
|
4.31687e-06
|
|
|
XPA
|
[NCBI]
|
4.2172e-06
|
|
|
GLB1
|
[NCBI]
|
4.2172e-06
|
|
|
AVPR2
|
[NCBI]
|
4.2172e-06
|
|
|
GC
|
[NCBI]
|
4.2172e-06
|
|
|
PIGA
|
[NCBI]
|
4.02483e-06
|
|
|
SLC18A3
|
[NCBI]
|
4.02483e-06
|
|
|
CD
|
[NCBI]
|
3.98779e-06
|
|
|
RSMD1
|
[NCBI]
|
3.87994e-06
|
|
|
PFIC1
|
[NCBI]
|
3.87994e-06
|
|
|
OPRM1
|
[NCBI]
|
3.84083e-06
|
|
|
TFR2
|
[NCBI]
|
3.84083e-06
|
|
|
PROCR
|
[NCBI]
|
3.84083e-06
|
|
|
ILK
|
[NCBI]
|
3.67761e-06
|
|
|
LOX
|
[NCBI]
|
3.66471e-06
|
|
|
PSAP
|
[NCBI]
|
3.66471e-06
|
|
|
SDS
|
[NCBI]
|
3.66211e-06
|
|
|
FCAS
|
[NCBI]
|
3.6317e-06
|
|
|
CLL
|
[NCBI]
|
3.6317e-06
|
|
|
ODDD
|
[NCBI]
|
3.6317e-06
|
|
|
GPI
|
[NCBI]
|
3.60376e-06
|
|
|
HEXB
|
[NCBI]
|
3.49606e-06
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
3.49606e-06
|
|
|
UMOD
|
[NCBI]
|
3.49606e-06
|
|
|
KSS
|
[NCBI]
|
3.43404e-06
|
|
|
CHAC
|
[NCBI]
|
3.39633e-06
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
3.39633e-06
|
|
|
apert syndrome
|
[NCBI]
|
3.39633e-06
|
|
|
FIH
|
[NCBI]
|
3.39633e-06
|
|
|
OA1
|
[NCBI]
|
3.33448e-06
|
|
|
F2R
|
[NCBI]
|
3.33448e-06
|
|
|
OPMD
|
[NCBI]
|
3.23915e-06
|
|
|
POAG
|
[NCBI]
|
3.17314e-06
|
|
|
HIGM1
|
[NCBI]
|
3.17314e-06
|
|
|
CVS
|
[NCBI]
|
3.17314e-06
|
|
|
SPDA1
|
[NCBI]
|
3.17314e-06
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
3.14804e-06
|
|
|
CNTF
|
[NCBI]
|
3.14279e-06
|
|
|
VIP
|
[NCBI]
|
3.02379e-06
|
|
|
PYY
|
[NCBI]
|
2.99741e-06
|
|
|
EGF
|
[NCBI]
|
2.89001e-06
|
|
|
NF1
|
[NCBI]
|
2.86517e-06
|
|
|
DKC
|
[NCBI]
|
2.76078e-06
|
|
|
A2M
|
[NCBI]
|
2.75205e-06
|
|
|
ANG
|
[NCBI]
|
2.75205e-06
|
|
|
HBB
|
[NCBI]
|
2.68302e-06
|
|
|
ABP1
|
[NCBI]
|
2.64588e-06
|
|
|
ACE
|
[NCBI]
|
2.43826e-06
|
|
|
krabbe disease
|
[NCBI]
|
2.26583e-06
|
|
|
ABCC2
|
[NCBI]
|
2.25809e-06
|
|
|
ATS
|
[NCBI]
|
2.21904e-06
|
|
|
F2
|
[NCBI]
|
2.14663e-06
|
|
|
CSF3
|
[NCBI]
|
2.14663e-06
|
|
|
APS1
|
[NCBI]
|
2.08202e-06
|
|
|
MAOA
|
[NCBI]
|
2.03957e-06
|
|
|
STAT6
|
[NCBI]
|
2.03957e-06
|
|
|
HEMB
|
[NCBI]
|
2.01167e-06
|
|
|
NOS3
|
[NCBI]
|
1.93675e-06
|
|
|
BIRC1
|
[NCBI]
|
1.93675e-06
|
|
|
MAG
|
[NCBI]
|
1.91931e-06
|
|
|
ALPS
|
[NCBI]
|
1.88843e-06
|
|
|
IAPP
|
[NCBI]
|
1.83896e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
1.83798e-06
|
|
|
TF
|
[NCBI]
|
1.77729e-06
|
|
|
WFS1
|
[NCBI]
|
1.7583e-06
|
|
|
KCNQ1
|
[NCBI]
|
1.74311e-06
|
|
|
ACHE
|
[NCBI]
|
1.6564e-06
|
|
|
GJA1
|
[NCBI]
|
1.63064e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
1.58719e-06
|
|
|
GPT
|
[NCBI]
|
1.56448e-06
|
|
|
DJS
|
[NCBI]
|
1.49096e-06
|
|
|
CCL22
|
[NCBI]
|
1.48045e-06
|
|
|
hemophilia a
|
[NCBI]
|
1.47035e-06
|
|
|
wilson disease
|
[NCBI]
|
1.45503e-06
|
|
|
B2M
|
[NCBI]
|
1.3223e-06
|
|
|
APP
|
[NCBI]
|
1.31602e-06
|
|
|
AKR1B1
|
[NCBI]
|
1.27841e-06
|
|
|
BSG
|
[NCBI]
|
1.24796e-06
|
|
|
FFI
|
[NCBI]
|
1.22069e-06
|
|
|
IL4
|
[NCBI]
|
1.17663e-06
|
|
|
FRAP1
|
[NCBI]
|
1.176e-06
|
|
|
PEDF
|
[NCBI]
|
1.13196e-06
|
|
|
HP
|
[NCBI]
|
1.07481e-06
|
|
|
TNFSF11
|
[NCBI]
|
1.04258e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
1.04258e-06
|
|
|
SMS
|
[NCBI]
|
1.02975e-06
|
|
|
BCR
|
[NCBI]
|
9.95449e-07
|
|
|
CAT
|
[NCBI]
|
9.35454e-07
|
|
|
SOD2
|
[NCBI]
|
8.65518e-07
|
|
|
HNPP
|
[NCBI]
|
7.6754e-07
|
|
|
DSG3
|
[NCBI]
|
7.53548e-07
|
|
|
NR1I2
|
[NCBI]
|
7.02997e-07
|
|
|
CMT1B
|
[NCBI]
|
6.13358e-07
|
|
|
NPY
|
[NCBI]
|
5.9361e-07
|
|
|
NS1
|
[NCBI]
|
5.86958e-07
|
|
|
ESR1
|
[NCBI]
|
5.64575e-07
|
|
|
GTS
|
[NCBI]
|
5.48331e-07
|
|
|
IHH
|
[NCBI]
|
5.22634e-07
|
|
|
UCP1
|
[NCBI]
|
4.82694e-07
|
|
|
PNMT
|
[NCBI]
|
4.82694e-07
|
|
|
TLR4
|
[NCBI]
|
4.78837e-07
|
|
|
SHBG
|
[NCBI]
|
4.59543e-07
|
|
|
ADCYAP1
|
[NCBI]
|
4.56224e-07
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
4.19783e-07
|
|
|
HAE
|
[NCBI]
|
4.19783e-07
|
|
|
TNFSF6
|
[NCBI]
|
4.19054e-07
|
|
|
LKS
|
[NCBI]
|
3.64636e-07
|
|
|
ABL
|
[NCBI]
|
3.64636e-07
|
|
|
SCZD
|
[NCBI]
|
3.64636e-07
|
|
|
MHS1
|
[NCBI]
|
3.64636e-07
|
|
|
CHAT
|
[NCBI]
|
3.43913e-07
|
|
|
OSM
|
[NCBI]
|
3.4302e-07
|
|
|
PPARA
|
[NCBI]
|
3.365e-07
|
|
|
HHT
|
[NCBI]
|
3.258e-07
|
|
|
HDC
|
[NCBI]
|
3.16191e-07
|
|
|
MAP2
|
[NCBI]
|
2.94974e-07
|
|
|
LCAT
|
[NCBI]
|
2.53053e-07
|
|
|
NGFB
|
[NCBI]
|
2.08758e-07
|
|
|
STAR
|
[NCBI]
|
1.82165e-07
|
|
|
PPARG
|
[NCBI]
|
1.41329e-07
|
|
|
SHH
|
[NCBI]
|
1.38017e-07
|
|
|
ACPP
|
[NCBI]
|
9.11259e-08
|
|
|
SLPI
|
[NCBI]
|
9.06931e-08
|
|
|
GUSB
|
[NCBI]
|
3.2509e-08
|
|
|
NPM1
|
[NCBI]
|
2.45449e-08
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
2.21637e-08
|
|
|
ACP5
|
[NCBI]
|
1.93785e-08
|
|
|
PMCH
|
[NCBI]
|
1.85302e-08
|
|
|
TNC
|
[NCBI]
|
1.77434e-08
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
1.31069e-08
|
|
|
PNPLA6
|
[NCBI]
|
7.53007e-09
|
|
|
BTK
|
[NCBI]
|
7.53007e-09
|
|
|
IL2
|
[NCBI]
|
7.08958e-09
|
|
|
PSACH
|
[NCBI]
|
5.08485e-09
|
|
|
SERPINA6
|
[NCBI]
|
5.01098e-09
|
|
|
PON1
|
[NCBI]
|
2.37434e-09
|
|
|
TPO
|
[NCBI]
|
2.01075e-09
|
|
|
LPI
|
[NCBI]
|
1.80145e-09
|
|
|
TFPI
|
[NCBI]
|
3.82588e-10
|
|